BIOTYPE GmbH

📢 Actionable insights for improved decision-making! Visit us and learn more about our innovative solutions for precision medicine at the #ADLM in Chicago from July 30 to August 1 at booth 318! 🧬 BIOTYPE provides a robust portfolio of molecular cancer diagnostics to support hemato-oncology, liquid biopsy, and molecular profiling of solid tumors. The portfolio comprises IVD assays for clinical diagnostics, RUO assays for translational and clinical research, and a benchtop system for automated molecular profiling. Our 4h workflow ensures rapid and precise cross-dimensional analysis of actionable biomarkers such as FGFR2/3, POLE, and MSI, in alignment with current guidelines. Discover our latest tests designed to deliver reliable results efficiently. Interested in learning more about BIOTYPE? 📩 Contact Norman Gerstner, Abhishek Aich, PhD or Marina L. and discover more about BIOTYPE's strong portfolio and our unique benchtop system for molecular multiplex testing – the MODAPLEX platform. We look forward to all the inspiring talks! 📅 July 30th – August 1st  🚩 McCormick Place Convention Center, Chicago, USA 📍 Booth 318 – joint DiagnostikNetBB booth #ADLM #Germany #precisiondiagnostics #biotechnology #CDMO #MODAPLEX

📣 BIOTYPE rocked the #REWETeamChallenge! 🏁   🏃♀️ Teaming up with our sister companies, ROTOP Pharmaka GmbH and qualitype GmbH, we formed a powerhouse team under the Molecular Diagnostics Group (MDG). Last Wednesday, our 11-member team took on a 5 km run through the heart of Dresden, soaking in the stunning city views.   At BIOTYPE, fostering a positive and collaborative work culture is key. Events like the #REWETeamChallenge are perfect for bringing our team together, strengthening bonds, and having a blast. Huge thanks to the organizers for an exciting event!   We can't wait for next year's challenge!

📢 Meet BIOTYPE at AMP Europe 2024! Meet Abhishek Aich, PhD at this year's Association for Molecular Pathology (AMP) 2024 Europe Congress, which will take place June 24-26, 2024, in Madrid, Spain and discuss how our products and services can meet your needs. Solid tumor genetic testing plays a vital role in confirming, staging, and successfully treating various types of cancer. Cost- and time- effective testing is the need of the hour. The MODAPLEX platform offers researchers, pathologists, and clinicians the advantage of consolidation of their PCR based testing needs, allowing cross-dimensional multi-biomarker analysis. Our advanced PCR-based solutions enable targeted molecular tumor profiling and diagnostics using FFPE material or Liquid Biopsy. Explore our latest innovations for the rapid and precise analysis of crucial biomarkers like ESR1, POLE, and FGFR, in accordance with current clinical guidelines. Arrange a meeting with Abhishek Aich, PhD and discover our portfolio for molecular profiling and diagnostics and our broad range of services! #AMPath2024 #SolidTumors #ESR1 #POLE #FGFR

📢 Meet BIOTYPE at #ESMOGynae24! Meet Abhishek Aich, PhD at this year's ESMO Gynaecological Cancers Congress 2024, which will take place in Florence, Italy on June 20 - 22, 2024, and discuss how our products and services can meet your needs. The MODAPLEX Endometrial Cancer PANEL enhances TCGA classification by merging three critical analyses — POLE/POLD1 mutations, microsatellite instability, and copy number variations — into a single MODAPLEX run. This efficient process provides comprehensive results in just 4 hours, conserves valuable FFPE tissue with minimal DNA input, and enables rapid decision-making for endometrial cancer classification. Discover how MODAPLEX enables the consolidation of all PCR-based diagnostic needs into a single run cross-dimensional multi-biomarker analysis. We would be delighted to arrange a meeting with you during the congress to address any questions you may have regarding the technical background of the assays or any other topics. Schedule a meeting with Abhishek Aich, PhD #GynaecologicalCancer #EndometrialCancer #ESMO24

📢 Meet BIOTYPE at #EHA2024!   Meet Marie Helbig at this year’s EHA congress taking place from June 13th to 16th in Madrid and discuss how our products and services can meet your needs.   Did you know that acute myeloid leukaemia (AML) is the most common type of acute leukaemia in adults? Early, fast, and accurate diagnosis of AML and its subtype is crucial for effective patient treatment.   Our Mentype® AMLplexQS and and the upcoming MODAPLEX AML Panel support the analysis of clinically relevant gene fusions or mutations in leukaemia using different technologies.   We would be delighted to arrange a meeting with you during the congress to address any questions you may have regarding the technical background of the assays, IVDR conformity or any other topics.   Schedule a meeting with Marie Helbig. #leukemia #hematooncology #chimerism #genotyping

Greetings from Geneva, where I am attending the #Global #Health #Summit. As satellite event of the seventy-seventh World Health Assembly, currently held in Geneva, Switzerland, the primary topic is all about improving global access to high-quality healthcare. Together with Timm Zörgiebel we are honored to represent BIOTYPE GmbH and our company group MDG in a panel discussion on "𝐓𝐡𝐞 𝐫𝐨𝐥𝐞 𝐨𝐟 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐢𝐧 𝐝𝐞𝐦𝐨𝐜𝐫𝐚𝐭𝐢𝐳𝐢𝐧𝐠 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐚𝐜𝐜𝐞𝐬𝐬." In precision medicine, the biggest challenge is broad access to the right combination of advanced therapies and comprehensive diagnostics. This combined availability is absolutely required to select the best possible treatment for the individual patient with a complex disease, no matter where you live. At MDG (BIOTYPE GmbH , ROTOP Pharmaka GmbH , qualitype GmbH) we focus on cost-effective and reliable products for comprehensive in vitro and in vivo diagnostics. BIOTYPE provides the necessary molecular diagnostic testing systems. Precision is the mission. #GlobalHealth #Health #Innovation #precisionmedicine #WHA77

🥳 That’s a wrap for this year’s #DGP2024! We had the incredible opportunity to attend the 107th Jahrestagung der deutschen Gesellschaft für Pathologie in Munich last week. The focus was on Next Generation Pathology with an emphasis on new molecular and computational pathology approaches for precision oncology. The discussions highlighted advancements in cancer diagnosis and treatment. Key takeaways: 🔬 The pivotal role of biomarkers in personalized medicine. 🧬 Advances in molecular pathology revolutionizing cancer care. 📊 Cutting-edge technologies driving precision oncology. A huge thank you to the organizers and speakers for an inspiring event. Special thanks to everyone who visited our booth - your interest and enthusiasm were greatly appreciated. Excited to bring these insights back to our team and explore new collaborations! 🤗 Special shoutout to the team behind Kongress- und Kulturmanagement GmbH for organizing the exhibition and to the Deutsche Gesellschaft für Pathologie e.V. for hosting this fantastic networking event. Missed connecting with us at the event? No problem! 🤝 Dive into the conversation by reaching out at: products@biotype.de #pathology #LiquidBiopsy #Droplex #Biomarkers #NextGenPathology #CancerResearch

Wertvoller Gastvortrag zu internationalen Themen des Healthcare Management 📢 Wir freuen uns, von einem inspirierenden Gastvortrag berichten zu können, der letzte Woche unter der Moderation von Prof. Dr. Dr. Philipp Plugmann MBA M.Sc. M.Sc. in unserem Master-Studiengang International Business & Leadership - Focus Healthcare Management stattfand. Jana Goss, Head of Regulatory Affairs der Biotype GmbH, hat uns mit ihrem umfassendem Wissen und spannenden Einblicken zur Zulassung von Medizinprodukten im US-Markt beeindruckt. In ihrem Arbeitsalltag verantwortet sie die regulatorischen Prozesse und Anforderungen für innovativste medizinische Produkte und Technologien. Ihre Ausführungen stießen bei unseren Studierenden auf großes Interesse und bauten optimal auf bisherigen Studieninhalte auf. Als kleines Dankeschön für ihren wertvollen Beitrag überreichte Prof. Dr. Dr. Philipp Plugmann Frau Goss das Buch "The Future Circle of Healthcare", in dem er mit Sepehr Ehsani, Prof. Dr. Patrick Glauner und Florian M. Thieringer beleuchtet, wie sich Innovationen im Gesundheitswesen in Bereichen wie KI und 3D-Druck auf die Zukunft des Gesundheitsmanagements, der Langlebigkeit und der Ethik auswirken werden. Wir sind sehr dankbar für ihre Zeit und Expertise und hoffen auf weitere inspirierende Vorträge in der Zukunft. Ein herzliches Dankeschön an Jana Goss und Prof. Dr. Dr. Philipp Plugmann für diesen bereichernden Austausch! #HealthcareManagement #Gastvortrag #SRHDresden #Gesundheitswesen #WissenTeilen

Wir sind auf der DGP 2024 mit Poster und Stand, kommt gerne vorbei ! 😃 unsere Standnummer: C10 #DGP2024

📢 Meet us at #EFI2024!   Meet Stefan Albrecht - Lienau at this year’s EFI congress and learn more about our diagnostic solutions allowing accurate and reliable chimerism monitoring.   Don’t be shy, contact Stefan and say hi!   He will be happy to answer all your questions and discuss how BIOTYPE can help facilitate the optimal application for your diagnostic needs. Don’t miss out on this opportunity to learn more about our innovative offerings in precision diagnostics.   Contact Stefan here: https://lnkd.in/eZy5GzAg #leukemia #hematooncology #chimerism